<DOC>
	<DOCNO>NCT02904512</DOCNO>
	<brief_summary>Several observational study show uncontrolled hyperglycemia hospitalize patient non-critical care , non-Intensive Care Unit ( non-ICU ) set associate prolonged length stay , increased mortality increase incidence infection . Randomized clinical trial critical non-ICU setting show improve glucose control decrease incidence infection , length stay inpatient health care cost . Continuous glucose monitoring ( CGM ) system evolve useful device provide excellent clinical care patient Diabetes Mellitus ( DM ) . These system detect glucose subcutaneous interstitial fluid use glucose sensor transmits glucose measurement receive device read average glucose level every couple minute . In clinical trial investigator propose examine clinical use CGM hospitalize patient Diabetes Mellitus type 2 ( DM2 ) . CGM use may improve glucometric value clinical outcome hospitalize individual Diabetes Mellitus type 2 ( DM2 ) ..</brief_summary>
	<brief_title>Inpatient Diabetes Mellitus ( DM ) Management With Continuous Glucose Monitoring Devices</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>History Diabetes Mellitus type 2 ( DM2 ) insulin Exclusion Criteria Patients expect require hospital stay ≤3 day Pregnant patient Subjects significant hyperglycemia Diabetic Ketoacidosis ( DKA ) require treatment intravenous insulin infusion Patients receive glucocorticosteroids dos ( equivalent ) ≥ 20 mg hydrocortisone/day Any mental condition render subject incapable understanding objective potential consequence study Patients need hospitalization critical care ( ICU ) set . History Diabetes Mellitus type 1 ( DM1 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>